Condition

Weight Management

ClinicalTrials.gov condition label

Clinical trials32
Recruiting10
Common interventions25
Lead sponsors shown15

Clinical trials

32 shown
Weight Management After Cancer for Survivors in Rural CommunitiesNCT07426952 · 2026-08-01
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMNCT07667803 · 2026-06-29
RECRUITING
Usability Study of Gestational and Postpartum Weight Management ProgramNCT07272824 · 2025-12-09
RECRUITING
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityNCT07243171 · 2025-11-18
RECRUITING
Advancing Biopsychosocial Care Training InitiativeNCT07049861 · 2025-07-14
RECRUITING
Mitigation of Cardiovascular Disease Risks in Children With Extreme ObesityNCT06967389 · 2025-06-12
RECRUITING
Family-Based Weight Wellness Treatment Through Food is Medicine and Group Medical Visits in Pediatric and Adult Primary CareNCT07717658 · 2025-02-05
RECRUITING
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body TypesNCT06691100 · 2024-10-16
RECRUITING
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)NCT06562907 · 2024-08-28
RECRUITING
Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With ObesityNCT06809166 · 2024-07-04
RECRUITING
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple DosesNCT07841860 · 2026-09-01
NOT_YET_RECRUITING
A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy ParticipantsNCT06506175 · 2026-07-01
NOT_YET_RECRUITING
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) TrialNCT07505303 · 2026-03-23
ACTIVE_NOT_RECRUITING
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)NCT07073417 · 2025-07-28
ACTIVE_NOT_RECRUITING
GV101 in Healthy Obese ParticipantsNCT06979505 · 2025-06-30
COMPLETED
Ashwagandha Extract for Weight and Stress Management in Overweight and Obese AdultsNCT07215455 · 2025-06-17
COMPLETED
Application-Assisted Weight Management in Endometrial Cancer Fertility PreservationNCT06901778 · 2025-03-31
NOT_YET_RECRUITING
Semaglutide in Treatment of ObesityNCT06604624 · 2024-09-20
COMPLETED
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With ObesityNCT06680440 · 2024-08-26
COMPLETED
A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep ApneaNCT06565871 · 2024-08-01
UNKNOWN
M4C Nutraceutical Intervention Human Health Effects PilotNCT06476236 · 2024-06-17
UNKNOWN
Healthy Lifestyles After Cancer for Adolescents and Young Adults: A Program to Reduce Cardiovascular Risk FactorsNCT05869604 · 2023-12-01
COMPLETED
Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial CancerNCT06312917 · 2023-08-01
COMPLETED
A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or ObesityNCT05813795 · 2023-04-05
COMPLETED
Mobile Internet Healthcare and Three Disciplines Co-management Intervention for Overweight/Obese Prediabetic PatientsNCT06147752 · 2023-03-28
UNKNOWN
Mindful Eating in Breast Cancer Survivors: A Pilot Study in TürkiyeNCT07007104 · 2022-05-03
COMPLETED
Obesity and Type 2 Diabetes - Raising the Issue of Weight Management in Primary CareNCT03360058 · 2017-10-07
COMPLETED
Satiating Effects of Isolated Soy ProteinsNCT01731197 · 2012-11-01
COMPLETED
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)NCT01511393 · 2012-01-01
ENROLLING_BY_INVITATION
A to Z Study Follow-up: Collection of DNA Data From Buccal SwabsNCT00866151 · 2008-08-01
UNKNOWN
A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body WeightNCT00542009 · 2007-12-01
COMPLETED
Effects of Protein-Enriched Meal on Liver, Kidney or Bone: a Randomized Controlled TrialNCT01030354 · 2004-07-01
COMPLETED

Common interventions

PlaceboDRUG6SemaglutideDRUG2Aerobic ExerciseBEHAVIORAL1ASC30DRUG1Ashwagandha 300 mg standardized root extractDIETARY_SUPPLEMENT1CE-326,597 100 mg QDDRUG1CE-326,597 25 mg QDDRUG1CE-326,597 50 mg QDDRUG1CE-326,597 5mg QDDRUG1Comprehensive Multidisciplinary Obesity CareOTHER1ContraveDRUG1Culinary medicine classesBEHAVIORAL1DEAR weight managementBEHAVIORAL1Diet ProgramBEHAVIORAL1Dry-Blended BeverageDIETARY_SUPPLEMENT1ECC4703DRUG1Ecnoglutide High DosageDRUG1Ecnoglutide Low DosageDRUG1Ecnoglutide Medium DosageDRUG1ecnoglutide tabletsDRUG1Education ControlOTHER1ElecoglipronDRUG1GS-4571DRUG1GV101DRUG1GV101 placeboDRUG1

Trial status mix

COMPLETED12
RECRUITING10
UNKNOWN4
NOT_YET_RECRUITING3
ACTIVE_NOT_RECRUITING2
ENROLLING_BY_INVITATION1

Phase mix

NA13
PHASE27
PHASE15
PHASE34
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.